Migraine is not simply pain. Recurrent attacks can interfere with work, relationships, and routine activities.
Chronic migraines are defined as headaches occurring on 15 or more days per month for at least three months, with at least eight of those days meeting migraine criteria. This is not a tension headache. It is a neurological condition driven by abnormal patterns of brain activity, nerve signaling, and vascular response.
For many patients, individual attacks blur into a near-constant baseline of head pain with intermittent severe flares.
Who Is This For
Migraines on 15 or more days per month. Medications have provided incomplete relief or cause unacceptable side effects. You want a preventive approach, not just treating attacks after they start. Migraines are worsening despite current management. You have been told this is something you have to live with.
Cortical hyperexcitability: the migraine-prone brain is more reactive to stimuli. Trigeminal nerve activation: the trigeminal nerve releases inflammatory compounds that dilate blood vessels in the meninges, producing throbbing pain. Central sensitization: repeated attacks lower the brain's pain threshold over time. Autonomic dysregulation: contributes to nausea, light sensitivity, and fatigue. Understanding that migraines are driven by nervous system dysfunction explains why neuromodulation and targeted intervention may help where conventional approaches have not.
Stress, sleep disruption, hormonal fluctuations, barometric pressure changes, certain foods and alcohol, bright or flickering lights, strong smells, dehydration, and neck tension. Trigger management is important but is rarely sufficient on its own for chronic migraines. In Fort McMurray, dramatic barometric pressure changes, extreme temperature swings, extended winter darkness, and shift work are well-documented migraine triggers that many residents live with year-round.
A Health Canada-approved medical treatment for chronic migraines, distinct from cosmetic Botox. Injected at specific points across the forehead, temples, back of the head, neck, and upper shoulders, targeting the nerve pathways involved in migraine generation. Works by blocking the release of neurotransmitters that carry pain signals, reducing frequency and severity before attacks start. Administered by a physician every 12 weeks. Most patients notice meaningful reduction after two to three treatment cycles. One of the most well-studied preventive migraine treatments with strong clinical evidence.
Delivers targeted electromagnetic stimulation to the brain regions involved in migraine generation and pain processing. May help reduce cortical hyperexcitability, calm trigeminal nerve pathways, support autonomic regulation, and help break the cycle of central sensitization. Non-invasive, no medication, no downtime. EXOMIND is used as a supportive therapy and may be most effective when combined with Therapeutic Botox and lifestyle modification.
Learn moreTrigger identification and management, sleep optimization, stress reduction, nutritional guidance, hormonal evaluation when migraines correlate with menstrual or menopausal patterns, and coordination with your neurologist or primary care physician.
Therapeutic Botox. Results typically develop after two to three treatment cycles, each 12 weeks apart. Some patients notice partial relief after the first cycle. EXOMIND. Improvement develops progressively over a series of sessions as nervous system patterns gradually shift. The goal is not just fewer migraines. It is a nervous system that is less reactive, less primed for pain, and better equipped to regulate itself. Chronic migraines are a neurological condition, not something you have to endure. Book a consultation. Your clinician will review your migraine history and explain which approach may help. Physician-led, no referral required.
Chronic migraines are not just frequent headaches. They represent a nervous system that has become progressively more reactive and less able to regulate itself. Each untreated attack may lower the threshold for the next one. Therapeutic Botox addresses the peripheral nerve component by blocking pain signal transmission. EXOMIND may address the central component by reducing the brain's overreactivity. Lifestyle and trigger management reduce the load on a nervous system already primed for pain. For most patients with chronic migraines, a single approach is less effective than a combined strategy. Your clinician will assess which combination is appropriate for your pattern.
The active ingredient is the same, but the purpose, injection sites, and dosage are different. Therapeutic Botox for migraines is a Health Canada-approved medical treatment targeting nerve pathways, not facial muscles.
Most patients notice meaningful improvement after two to three cycles. Some notice partial relief after the first.
Yes. Therapeutic Botox is often used in combination with other preventive or acute migraine treatments. Your clinician will coordinate with your existing medical team.
No. You can book directly. Your clinician will assess whether Therapeutic Botox, EXOMIND, or both are appropriate for your migraine pattern.
It is used as a supportive therapy. It may be most effective when combined with Therapeutic Botox, trigger management, and lifestyle modification.
Book a consultation to discuss your concerns in a confidential, professional setting and create a personalized treatment plan.
Book a Consultation